Hadiza Khamofu
FHI 360
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hadiza Khamofu.
Journal of the International AIDS Society | 2012
Solomon Odafe; Ochanya Idoko; Titilope Badru; Bolatito Aiyenigba; Chiho Suzuki; Hadiza Khamofu; Emeka Okechukwu; Kwasi Torpey; Otto Chabikuli
Clinical outcome is an important determinant of programme success. This study aims to evaluate patients’ baseline characteristics as well as level of care associated with lost to follow‐up (LTFU) and mortality of patients on antiretroviral treatment (ART).
PLOS ONE | 2012
Solomon Odafe; Kwasi Torpey; Hadiza Khamofu; Obinna Ogbanufe; Edward Adekola Oladele; Oluwatosin Kuti; Oluwasanmi Adedokun; Titilope Badru; Emeka Okechukwu; Otto Chabikuli
Objective To evaluate the rate and factors associated with attrition of patients receiving ART in tertiary and secondary hospitals in Nigeria. Methods and Findings We reviewed patient level data collected between 2007 and 2010 from 11 hospitals across Nigeria. Kaplan-Meier product-limit and Cox regression were used to determine probability of retention in care and risk factors for attrition respectively. Of 6,408 patients in the cohort, 3,839 (59.9%) were females, median age of study population was 33years (IQR: 27–40) and 4,415 (69%) were from secondary health facilities. The NRTI backbone was Stavudine (D4T) in 3708 (57.9%) and Zidovudine (ZDV) in 2613 (40.8%) of patients. Patients lost to follow up accounted for 62.7% of all attrition followed by treatment stops (25.3%) and deaths (12.0%). Attrition was 14.1 (N = 624) and 15.1% (N = 300) in secondary and tertiary hospitals respectively (p = 0.169) in the first 12 months on follow up. During the 13 to 24 months follow up period, attrition was 10.7% (N = 407) and 19.6% (N = 332) in secondary and tertiary facilities respectively (p<0.001). Median time to lost to follow up was 11.1 (IQR: 6.1 to 18.5) months in secondary compared with 13.6 (IQR: 9.9 to 17.0) months in tertiary sites (p = 0.002). At 24 months follow up, male gender [AHR 1.18, 95% CI: 1.01–1.37, P = 0.038]; WHO clinical stage III [AHR 1.30, 95%CI: 1.03–1.66, P = 0.03] and clinical stage IV [AHR 1.90, 95%CI: 1.20–3.02, p = 0.007] and care in a tertiary hospital [AHR 2.21, 95% CI: 1.83–2.67, p<0.001], were associated with attrition. Conclusion Attrition could potentially be reduced by decentralizing patients on ART after the first 12 months on therapy to lower level facilities, earlier initiation on treatment and strengthening adherence counseling amongst males.
AIDS | 2015
Kate M. Mitchell; Aurélia Lépine; Fern Terris-Prestholt; Kwasi Torpey; Hadiza Khamofu; Morenike Oluwatoyin Folayan; Jonah Musa; James Anenih; Atiene S. Sagay; Emmanuel Alhassan; John Idoko; Peter Vickerman
Objective:To estimate the impact and cost-effectiveness of treatment as prevention (TasP), pre-exposure prophylaxis (PrEP) and condom promotion for serodiscordant couples in Nigeria. Design:Mathematical and cost modelling. Methods:A deterministic model of HIV-1 transmission within a cohort of serodiscordant couples and to/from external partners was parameterized using data from Nigeria and other African settings. The impact and cost-effectiveness were estimated for condom promotion, PrEP and/or TasP, compared with a baseline where antiretroviral therapy (ART) was offered according to 2010 national guidelines (CD4+ <350 cells/&mgr;l) to all HIV-positive partners. The impact was additionally compared with a baseline of current ART coverage (35% of those with CD4+ <350 cells/&mgr;l). Full costs (in US
Nigerian Medical Journal | 2013
Solomon Odafe; Kwasi Torpey; Hadiza Khamofu; Edward Oladele; Oluwasanmi Adedokun; Otto Chabikuli; Halima Mukaddas; Yelwa Usman; Bolatito Aiyenigba; MacPaul Okoye
2012) of programme introduction and implementation were estimated from a provider perspective. Results:Substantial benefits came from scaling up ART to all HIV-positive partners according to 2010 national guidelines, with additional smaller benefits of providing TasP, PrEP or condom promotion. Compared with a baseline of offering ART to all HIV-positive partners at the 2010 national guidelines, condom promotion was the most cost-effective strategy [US
PLOS ONE | 2017
Edward Adekola Oladele; Hadiza Khamofu; Seun Asala; Mariya Saleh; Uche Ralph-Opara; Charles Nwosisi; Chukwuma Anyaike; Catherine Gana; Oluwasanmi Adedokun; Rebecca Dirks; Olufunsho Adebayo; Modupe Oduwole; Justin Mandala; Kwasi Torpey
1206/disability-adjusted-life-year (DALY)], the next most cost-effective intervention was to additionally give TasP to HIV-positive partners (incremental cost-effectiveness ratio US
Vulnerable Children and Youth Studies | 2016
Catherine Gana; Edward Oladele; Mariya Saleh; Osagbemi Makanjuola; Diana Gimba; Doreen Magaji; Temitayo Odusote; Hadiza Khamofu; Kwasi Torpey
1607/DALY), followed by additionally giving PrEP to HIV-negative partners until their HIV-positive partners initiate ART (US
Journal of HIV and Human Reproduction | 2015
Hadiza Khamofu; Edward Oladele; Uche Ralph-Opara; Titi Badru; Oluwasanmi Adedokun; Mariya Saleh; McPaul Okoye; Olufunsho Adebayo; Kwasi Torpey
7870/DALY). When impact was measured in terms of infections averted, PrEP with condom promotion prevented double the number of infections as condom promotion alone. Conclusions:The first priority intervention for serodiscordant couples in Nigeria should be scaled up ART access for HIV-positive partners. Subsequent incremental benefits are greatest with condom promotion and TasP, followed by PrEP.
Vulnerable Children and Youth Studies | 2014
Catherine Gana; Edward Oladele; Chukwuemeka Anoje; Mariya Saleh; Philomena Irene; Hadiza Khamofu; Kwasi Torpey; Otto N. Chabikuli
Background: Human immunodeficiency virus positive (HIV+) women have a higher risk of developing invasive cervical cancer compared with uninfected women. This study aims to document programmatic experience of integrating cervical cancer screening using Visual Inspection and Acetic Acid (VIA) into HIV care as well as to describe patients’ characteristics associated with positive VIA findings amongst HIV+ women. Materials and Methods: A cross-sectional study analysed routine service data collected at the antiretroviral therapy (ART) and cervical cancer screening services. Our program integrated screening for cervical cancer using VIA technique to HIV care and treatment services through a combination of stakeholder engagement, capacity building for health workers, creating a bi-directional referral between HIV and reproductive health (RH) services and provider initiated counselling and screening for cervical cancer. Information on patients’ baseline and clinical characteristics were captured using an electronic medical records system and then exported to Statistical Package for the Social Sciences (SPSS). Logistic regression model was used to estimate factors that influence VIA results. Results: A total of 834 HIV+ women were offered VIA screening between April 2010 and April 2011, and 805 (96.5%) accepted it. Complete data was available for 802 (96.2%) women. The mean age at screening and first sexual contact were 32.0 (SD 6.6) and 18.8 (SD 3.5) years, respectively. VIA was positive in 52 (6.5%) women while 199 (24.8%) had a sexually transmitted infection (STI). Of the 199 who had a STI, eight (4.0%) had genital ulcer syndrome, 30 (15.1%) had lower abdominal pain syndrome and 161 (80.9%) had vaginal discharge syndrome. Presence of lower abdominal pain syndrome was found to be a significant predictor of a positive VIA result (P = 0.001). Women with lower abdominal pain syndrome appeared to be more likely (OR 47.9, 95% CI: 4.8-480.4, P = 0.001) to have a positive VIA result. Conclusion: The high burden of both HIV and cervical cancer in developing countries makes it a necessity for integrating services that offer early detection and treatment for both diseases. The findings from our study suggest that integrating VIA screening into the package of care offered to HIV+ women is feasible and acceptable.
The Lancet Global Health | 2018
E Oladele; William Nii Ayitey Menson; O-O Badejo; E Onwasigwe; I Iyamu; A Olarinoye; C Agbakwuru; Tamara Bruno; Hadiza Khamofu; Echezona E. Ezeanolue
Introduction As the world is making progress towards elimination of mother-to-child transmission of HIV, poor coverage of PMTCT services in Nigeria remains a major challenge. In order to address this, scale-up was planned with activities organized into 3 phases. This paper describes the process undertaken in eight high burden Nigerian states to rapidly close PMTCT coverage gaps at facility and population levels between February 2013 and March 2014. Methods Activities were grouped into three phases–pre-assessment phase (engagement of a wide range of stakeholders), assessment (rapid health facility assessment, a cross sectional survey using mixed methods conducted in the various states between Feb and May 2013 and impact modelling), and post-assessment (drawing up costed state operational plans to achieve eMTCT by 2015, data-driven smart scale-up). Results Over a period of 10 months starting June 2013, 2044 facilities were supported to begin provision of PMTCT services. This increased facility coverage from 8% to 50%. A 246% increase was also recorded in the number of pregnant women and their families who have access to HIV testing and counselling in the context of PMTCT. Similarly, access to antiretrovirals for PMTCT has witnessed a 152% increase in these eight states between October 2013 and October 2014. Conclusion A data-driven and participatory approach can be used to rapidly scale-up PMTCT services at community and facility levels in this region. These results present us with hope for real progress in Nigeria. We are confident that the efforts described here will contribute significantly to eliminating new pediatric HIV infection in Nigeria.
Journal of the International AIDS Society | 2018
Edward Oladele; Okikiolu A Badejo; Christopher Obanubi; Emeka Okechukwu; Ezekiel James; Golden Owhonda; Onuche I Omeh; Moyosola Abass; Olubunmi Ruth Negedu-Momoh; Norma Ojehomon; Dorothy Oqua; Satish Raj-Pandey; Hadiza Khamofu; Kwasi Torpey
ABSTRACT This study describes the characteristics of caregivers, examines the relationships between caregivers and their children and analyzes the experiences and challenges of caring for orphans and vulnerable children (OVC) faced by caregivers in the community. Using a combination of questionnaire, informant interviews and focus group discussions, data were collected from 150 female and male caregivers in Cross Rivers State and the Federal Capital Territory selected through convenient sampling. Careful analysis of the data revealed that majority of the caregivers were women, mostly widows caring for about 3–6 children. They were largely married with primary or no formal education. Most of them were engaged in petty trading and farming. Their incomes were generally low, less than 10,000 naira (approximately 52 dollars) per annum. Challenges of caring for children were listed to include; lack of access to education, nutrition, inadequate clothing and shelter and lack of psychosocial support in that order. Family supports to these caregivers have either dwindled considerably or non-existent. In the words of these caregivers, our relatives have their own problems in this era of economic crisis to bother about the problems of other people. A few of the organized supports came from non-governmental organizations and faith-based organizations in the form of handouts to meet needs of food and school supplies. These do not address the root cause of caregivers’ problems of lack of skills and income generation for sustainable care. The study recommends empowering caregivers as a sustainable approach to the problem of vulnerable children in the community.